SHC 2019 Conference Programme

Scientific Programme for the Singapore Hepatology Conference (SHC) 2020 will be available soon. Stay tuned for further updates.

Meeting Venue:  Summit 2, Level 3, Suntec Singapore

Time

Programme

08:30 – 09:45

08:30 – 8:45

Welcome Remarks by the Conference Chairman and SHC partners

Combined

CHB Therapy

 

Chairs: Raj Reddy (USA), Tan Chee Kiat (Singapore)

 

08:45 – 09:00

Optimisation of Current CHB Therapy

 

Geoffrey Dusheiko, UK

 

09:00 – 09:15

Practical Management of Hepatitis B in Special Groups (Immunosupp, Pregnancy)

 

Teerha Piratvisuth, Thailand

 

09:15 – 09:30

Future Therapies for HBV Leading to Functional Cure

 

Fabien Zoulim, France

 

09:30 – 09:45

Round table discussion

09:45 –  10:00

Tea Break

10:00 –  10:45

CHB Treatment Special Groups

Clinical

Chairs: Raj Reddy (USA), Tan Chee Kiat (Singapore)

 

10:00 – 10:15

The Good and Bad of Hepatitis B Flares

 

Tarik Asselah, France

 

10:15 – 10:30

CHB and Cirrhosis: Factors in Progression or Regression?

 

Teerha Piratvisuth, Thailand

 

10:30 – 10:45

Round table discussion

10:45 – 11:45

Controversial Issues in CHB

Clinical

Chairs: Rinaldi Lesmana (Indonesia),  Edward Gane (New Zealand)

 

10:45 – 11:15

Debate: Should We Treat CHB to Prevent HCC?

 

·         To Treat: Ray Kim, USA

 

·         Not to treat: Jorg Peterson, Germany

 

11:15 – 11:45

Round table discussion

11:45 – 13:30

HBV-HCC Lunch Case Discussion

Clinical

Moderator: Guan Huei Lee (Singapore)

 

Panelists: Pei-Jer Chen (Taiwan) , Kwang-Hyub Han (Korea) , Tan Chee Kiat (Singapore), Robert Gish (USA)

13:30 – 15:15

HCC Symposium Part 1

Clinical

Chairs: Tan Chee Kiat (Singapore), Robert Gish (USA)

 

13:30 – 13:45

Molecular and Immune Pathways in HCC Pathogenesis

 

Pei-Jer Chen, Taiwan

 

13:45 – 14:00

New Diagnostic and Surveillance Tools for Early Detection of HCC

 

Robert Gish, USA

 

14:00 – 14:45

Debate: Management of Small HCC

 

·         Surgery: Pierce Chow, Singapore

 

·         Loco-regional Therapy: Kwang-hyub Han, Korea

 

·         Liver Transplant: Glenn Bonney, Singapore

 

 

Forum for Management of Small HCC: Therapeutic Options and Patient Selection

 

Moderator:  Tan Poh Seng (Singapore)

14:45 – 15:15

Panelists: Pei-Jer Chen (Taiwan), Kwang-Hyub Han (Korea), Pierce Chow (Singapore), Glenn Bonney (Singapore), Tan Chee Kiat (Singapore)

15:15 – 15:30

Tea Break

15:30 – 16:30

HCC Symposium Part 2

Clinical

Chairs: Robert Gish (USA),  Chee Cheng Ean (Singapore)

 

15:30 – 15:45

Immunotherapy for HCC: The New Frontier?

 

Toh Han Chong, Singapore

 

15:45 – 16:00

Combination Therapy or Sequential Therapy of HCC

 

Chee Cheng Ean (Singapore)

 

16:00 – 16:15

Debate: Systemic Therapy for HCC Should be Managed by Oncologists

 

Chee Cheng Ean, Singapore

 

16:15 – 16:30

Debate: Systemic Therapy for HCC Should be Managed by Hepatologists

 

Robert Gish, USA

16:30 – 18:00

Systemic Therapy for HCC Case Discussion

Clinical

Moderator Chee Cheng Ean (Singapore)

 

16:30 – 18:00

Panelists: Toh Han Chong Singapore), Pierce Chow (Singapore), Tan Chee Kiat (Singapore)

 

 

End of day 1

Meeting Venue:  Summit 2, Level 3, Suntec Singapore

Time

Programme

 09:00 – 10:45

HCV Management

Clinical

Chairs:  Khin Maung Win (Myanmar), Tan Soek Siam (Malaysia)

 

09:00 – 09:30

Debate: Management for HCV Should be Personalised

 

·         For : Raj Reddy, USA

 

·         Against : Edward Gane, New Zealand

 

09:30 – 09:45

DAA Induced HCC – Fact or Fiction?

 

Diana Payawal, Philippines

 

09:45 – 10:00

DAA Treatment Failures and Resistance:

 

Tarik Asselah, France

 

10:00 – 10:15

Difficult to treat Patients: CKD

 

Rosmawati Mohamed, Malaysia

 

10:15 – 10:45

Post SVR Follow Up

 

Khin Maung Win, Myanmar

10:45 – 11:00

Tea Break

11:00 – 12:15

Hot Topics in Hepatology Symposium

Clinical

Chairs: Rino Gani (Indonesia)

 

11:00 – 11:15

Non-invasive / Invasive Diagnosis of Liver Fibrosis: Serological, Mechanical or Both?

 

Chan Wah Kheong, Malaysia

 

11:15 – 11:30

New Treatments for Autoimmune and Cholesteric Liver Disease

 

Raj Reddy, USA

 

11:30 – 11:45

Update on Metal Disease Affecting the Liver: An Asia Pacific Perspective

 

Darrell Crawford, Australia

 

11:45 – 12:00

Alcoholic Liver Disease: A Problem in Asia?

 

Samir Shah, India

 

12:00 – 12:15

Round table discussion

12:15– 14:00

HCV-NASH Lunch Case Discussion 

Clinical

Moderator: Dan Yock Young (Singapore)

 

Panelists:  Teerha Piratvisuth (Thailand) , Samir Shah (India) , Jacob George (Australia), George Goh (Singapore), Chan Wah Kheong (Malaysia)

14:00 – 15:45

Non-Alcoholic Fatty Liver Disease Symposium

Clinical

Chairs: Yock Young Dan (Singapore), George Goh (Singapore)

 

14:00 – 14:15

Pathophysiology and Risk Factors for NAFLD

 

George Goh, Singapore

 

14:15 – 14:30

NAFLD and the Microbiome

 

Yock Young Dan, Singapore

 

14:30 – 14:45

Optimising Comprehensive Management of NASH

 

Chan Wah Kheong, Malaysia

 

14:45 – 15:15

Debate: Role of Statin. Should Vitamin E be Used to Treat Obesity/Treat NASH? How long? Should We Biopsy NASH?

 

·       Yes: Darrell Crawford, Australia

 

·       No: Raj Reddy, USA

 

15:15 – 15:30

New Therapeutics for NASH: Can We Pick the Winners?

 

Jacob George, Australia

 

15:30 – 15:45

Discussion Forum

15:45 – 16:00

Tea Break

15:45 – 17:30

Advanced Liver Disease Symposium

Clinical

Chairs: Teerha Piratvisuth (Thailand), Tan Soek Siam (Malaysia), Kyaw Soe Tun (Myanmar)

 

16:00 – 16:15

Sarcopenia in Cirrhosis

 

Ray Kim, USA

 

16:15 – 16:30

Update on Management of Portal Hypertension

 

Raj Reddy, USA

 

16:30 – 16:45

Acute on Chronic Liver Failure

 

Yogesh  Chawla, India

 

16:45 – 17:00

Diuretic Resistant Ascites

 

Rino Gani, Indonesia

 

17:00 – 17:15

Current Trends in Liver Transplantation in Asia

 

James Fung, Hong Kong

 

17:15 – 17:30

Round table discussion

17:30

Conclusion

The programme is accruate as of 28 May 2019 and subject to change